RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients Article

Chakravarti, Arnab, Wang, Meihua, Robins, H Ian et al. (2013). RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85(5), 1206-1211. 10.1016/j.ijrobp.2012.10.008

Open Access International Collaboration

cited authors

  • Chakravarti, Arnab; Wang, Meihua; Robins, H Ian; Lautenschlaeger, Tim; Curran, Walter J; Brachman, David G; Schultz, Christopher J; Choucair, Ali; Dolled-Filhart, Marisa; Christiansen, Jason; Gustavson, Mark; Molinaro, Annette; Mischel, Paul; Dicker, Adam P; Bredel, Markus; Mehta, Minesh

sustainable development goals

authors

publication date

  • April 1, 2013

webpage

published in

keywords

  • BREAST-CANCER
  • EXPRESSION
  • GROWTH-FACTOR RECEPTOR
  • II TRIAL
  • KINASE
  • Life Sciences & Biomedicine
  • MEDIATES RESISTANCE
  • MULTIFORME
  • Oncology
  • RADIOTHERAPY
  • RECURRENT GLIOBLASTOMA
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1206

end page

  • 1211

volume

  • 85

issue

  • 5